OUTCOMES AFTER REPEAT TRANSSPHENOIDAL SURGERY FOR RECURRENT CUSHING'S DISEASE-Reference-Cited by-同舟云学术

OUTCOMES AFTER REPEAT TRANSSPHENOIDAL SURGERY FOR RECURRENT CUSHING'S DISEASE

Published:2008-08-01 Issue:2 Volume:63 Page:266-271
ISSN:0148-396X
Container-title:Neurosurgery
language:en
Short-container-title:

Author:

Patil Chirag G.¹,Veeravagu Anand¹,Prevedello Daniel M.²,Katznelson Laurence¹,Vance Mary L.³,Laws Edward R.⁴

Affiliation:

1. Department of Neurosurgery, Stanford University School of Medicine, Stanford, California

2. Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

3. Department of Internal Medicine-Endocrinology, University of Virginia Health System, Charlottesville, Virginia

4. Departments of Neurosurgery, University of Virginia Health System, Charlottesville, Virginia, and Stanford University School of Medicine, Stanford, California

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Clinical Neurology,Surgery

Link

http://academic.oup.com/neurosurgery/article-pdf/63/2/266/24548511/00006123-200808000-00017.pdf

Reference17 articles.

1. Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma;Benveniste;J Neurosurg,2005

2. Gamma knife radiosurgery is a successful adjunctive treatment in Cushing's disease;Castinetti;Eur J Endocrinol,2007

3. Transsphenoidal pituitary surgery in Cushing's disease: Can we predict outcome?;Chee;Clin Endocrinol (Oxf),2001

4. The efficacy of linear accelerator radiosurgery in the management of patients with Cushing's disease;Devin;Stereotact Funct Neurosurg,2004

5. Repeat transsphenoidal surgery for Cushing's disease;Friedman;J Neurosurg,1989

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Granulation Patterns of Functional Corticotroph Tumors Correlate with Tumor Size, Proliferative Activity, T2 Intensity-to-White Matter Ratio, and Postsurgical Early Biochemical Remission;Endocrine Pathology;2024-07-24

2. Current and Emerging Pharmacological Therapies for Cushing's Disease;Current Pharmaceutical Design;2024-03

3. Case Report: Opposite Tumoral and Hormonal Responses to Low-dose Pasireotide in Cushing’s Disease;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-11-03

4. Clinical decision-making based on 11C-methionine PET in recurrent Cushing’s disease with equivocal MRI findings;Journal of Neurosurgery;2023-06-01

5. Unmet needs on the current medical management of Cushing’s syndrome: results from a Delphi panel of Italian endocrinologists;Journal of Endocrinological Investigation;2023-04-19